New and developing therapies for atopic dermatitis

Tamar Hajar, João Renato Vianna Gontijo, Jon Hanifin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.

Original languageEnglish (US)
Pages (from-to)104-107
Number of pages4
JournalAnais Brasileiros de Dermatologia
Volume93
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Atopic Dermatitis
Disease Management
Skin Diseases
Adrenal Cortex Hormones
Therapeutics
Pharmaceutical Preparations

Keywords

  • Dermatitis, atopic
  • Eczema
  • Phosphodiesterase inhibitors
  • Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

New and developing therapies for atopic dermatitis. / Hajar, Tamar; Gontijo, João Renato Vianna; Hanifin, Jon.

In: Anais Brasileiros de Dermatologia, Vol. 93, No. 1, 01.01.2018, p. 104-107.

Research output: Contribution to journalArticle

Hajar, Tamar ; Gontijo, João Renato Vianna ; Hanifin, Jon. / New and developing therapies for atopic dermatitis. In: Anais Brasileiros de Dermatologia. 2018 ; Vol. 93, No. 1. pp. 104-107.
@article{00d538f950be41a18dce6829e09f6d53,
title = "New and developing therapies for atopic dermatitis",
abstract = "Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.",
keywords = "Dermatitis, atopic, Eczema, Phosphodiesterase inhibitors, Therapeutics",
author = "Tamar Hajar and Gontijo, {Jo{\~a}o Renato Vianna} and Jon Hanifin",
year = "2018",
month = "1",
day = "1",
doi = "10.1590/abd1806-4841.20187682",
language = "English (US)",
volume = "93",
pages = "104--107",
journal = "Anais Brasileiros de Dermatologia",
issn = "0365-0596",
publisher = "Sociedade Brasileira de Dermatologia",
number = "1",

}

TY - JOUR

T1 - New and developing therapies for atopic dermatitis

AU - Hajar, Tamar

AU - Gontijo, João Renato Vianna

AU - Hanifin, Jon

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.

AB - Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.

KW - Dermatitis, atopic

KW - Eczema

KW - Phosphodiesterase inhibitors

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85045076682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045076682&partnerID=8YFLogxK

U2 - 10.1590/abd1806-4841.20187682

DO - 10.1590/abd1806-4841.20187682

M3 - Article

VL - 93

SP - 104

EP - 107

JO - Anais Brasileiros de Dermatologia

JF - Anais Brasileiros de Dermatologia

SN - 0365-0596

IS - 1

ER -